Forskning

by Doug Brunk FROM THE ANNUAL MEETING OF THE ENDOCRINE SOCIETY SAN DIEGO — The scale that weighs risks and benefits tips more favorably for newly menopausal women who begin hormone therapy at age 50-59 years and who use it for 5 years, compared with women who start the therapy in their 60s, according to [...]

Kate Maclaran; John C Stevenson Authors and Disclosures Posted: 01/03/2012; Women’s Health. 2012;8(1):63-74. © 2012 Future Medicine Ltd. Abstract Prevention of cardiovascular disease has increasingly important health implications as our population ages. Menopause is associated with the development of cardiovascular risk factors and there are many plausible biological mechanisms through which estrogen may confer cardiovascular protection. Despite a wealth [...]

ScienceDaily (Dec. 9, 2010) While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk, according to study results presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer [...]

December 2011, Vol. 14, No. 6 , Pages 633-636 (doi:10.3109/13697137.2011.590618) Read More: http://informahealthcare.com/doi/abs/10.3109/13697137.2011.590618 J. C. Stevenson, H. N. Hodis*, J. H. Pickar† and R. A. Lobo† National Heart & Lung Institute, Imperial College London, Royal Brompton Hospital, London , UK *Atherosclerosis Research Unit, Keck School of Medicine, University of Southern California, Los Angeles, CA , [...]

Wall Street Journal SEPTEMBER 27, 2011 The 25 million American women turning 50 in the next decade face a vexing decision: Hormone replacement therapy? Or not. There’s still no simple answer. For years, estrogen was seen as a fountain of youth that would keep women healthy and sexy long after menopause. Then in 2002, the [...]

ScienceDaily (Dec. 9, 2010) — While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk, according to study results presented at the 33rd Annual CTRC-AACR San Antonio Breast [...]

Scarabin PY, Oger E, Plu-Bureau G; EStrogen and THromboEmbolism Risk Study Group. Source INSERM Cardiovascular Epidemiology Unit U258, Villejuif, France. scarabin@vjf.inserm.fr <scarabin@vjf.inserm.fr> Abstract BACKGROUND: Oral oestrogen-replacement therapy (ERT) activates blood coagulation and increases the risk of venous thromboembolism (VTE) in postmenopausal women. Transdermal ERT has little effect on haemostasis, but data assessing its effect on [...]

Kate Maclaran; John C Stevenson Posted: 01/03/2012; Women’s Health. 2012;8(1):63-74. © 2012 Future Medicine Ltd. Abstract Prevention of cardiovascular disease has increasingly important health implications as our population ages. Menopause is associated with the development of cardiovascular risk factors and there are many plausible biological mechanisms through which estrogen may confer cardiovascular protection. Despite a wealth of observational data [...]